Hirano, K <br/><br/>
Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase.  [electronic resource] 

 -  Arteriosclerosis, thrombosis, and vascular biology  Nov 1995 
 - 1849-56 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1079-5642 
<br/><br/><label>Standard No.: </label>10.1161/01.atv.15.11.1849  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Apolipoproteins--metabolism<br/>Arteriosclerosis--blood<br/>Biomarkers<br/>Carrier Proteins--blood<br/>Cholesterol Ester Transfer Proteins<br/>Female<br/>Glycoproteins<br/>Humans<br/>Hyperlipoproteinemias--blood<br/>Lipase--blood<br/>Male<br/>Middle Aged<br/>Mutation